U.S. Pharmacist Weekly News Update
April 24, 2019

Statin Adherence Low For Secondary CVD Prevention
Statins can halve the risk for a second major CVD event, but only if patients actually take the drugs as prescribed. Find out how few patients who already have had coronary artery disease follow physician instructions on taking anticholesterol medications.


Many Patients Taking Statins Don’t Reach Recommended
LDL Levels

As difficult as it might be to get patients to adhere to their statin regimens, that might not be enough, according to a new study. Researchers report that, even with cholesterol-lowering therapy, half of patients don’t reach optimal LDL levels after 2 years. Here is more information.

A Third of Cancer Patients Use Often-Undisclosed Complementary Therapies
Pharmacists might want to ask some extra questions when they are filling prescriptions for patients being treated for cancer or those who are survivors. A new survey finds that a third of those patients use complementary/alternative therapies and, for a variety of reasons, don’t disclose that information to healthcare professionals. Here are the details.

BPH Medications Linked to Increased Type 2 Diabetes Risk
While a new study doesn’t suggest any change in usage guidelines, it points out that common benign prostate hyperplasia treatment is associated with increased risk for type 2 diabetes. Find out how much the risk is increased, with which drugs, and what can be done about it.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App